- Home
- HIMS vs CORT Comparison
HIMS vs CORT Comparison
Compare HIMS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIMS
- CORT
- Stock Information
- Founded
- HIMS 2017
- CORT 1998
- Country
- HIMS United States
- CORT United States
- Employees
- HIMS N/A
- CORT N/A
- Industry
- HIMS Medical/Nursing Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- HIMS Health Care
- CORT Health Care
- Exchange
- HIMS Nasdaq
- CORT Nasdaq
- Market Cap
- HIMS 6.6B
- CORT 5.9B
- IPO Year
- HIMS N/A
- CORT N/A
- Fundamental
- Price
- HIMS $26.19
- CORT $51.40
- Analyst Decision
- HIMS Buy
- CORT Strong Buy
- Analyst Count
- HIMS 14
- CORT 4
- Target Price
- HIMS $23.71
- CORT $75.25
- AVG Volume (30 Days)
- HIMS 16.7M
- CORT 908.1K
- Earning Date
- HIMS 11-04-2024
- CORT 02-13-2025
- Dividend Yield
- HIMS N/A
- CORT N/A
- EPS Growth
- HIMS N/A
- CORT 57.97
- EPS
- HIMS 0.44
- CORT 1.26
- Revenue
- HIMS $1,241,994,000.00
- CORT $628,555,000.00
- Revenue This Year
- HIMS $71.33
- CORT $46.29
- Revenue Next Year
- HIMS $37.95
- CORT $17.09
- P/E Ratio
- HIMS $58.94
- CORT $40.77
- Revenue Growth
- HIMS 56.70
- CORT 39.67
- 52 Week Low
- HIMS $8.09
- CORT $20.84
- 52 Week High
- HIMS $35.02
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- HIMS 44.33
- CORT 37.49
- Support Level
- HIMS $24.62
- CORT $53.51
- Resistance Level
- HIMS $33.14
- CORT $60.90
- Average True Range (ATR)
- HIMS 2.70
- CORT 2.69
- MACD
- HIMS -0.92
- CORT -1.24
- Stochastic Oscillator
- HIMS 15.26
- CORT 11.31
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.